can you use glp 1 with sglt2 inhibitors-what do guidelines say? a The EASD and the ADA jointly SGLT2 Inhibitors vs. GLP-1 Agonists
Description
Because GI symptoms are the leading cause of treatment discontinuation [10,12], implementing preventive and management strategies is essential to maximize adherence and therapeutic benefit
46% were White, 50% were Asian, and 3% were Black or African American
Look for board certification in obesity medicine or a related specialty
The regions focus on evidence-based treatment protocols, with favorable reimbursement policies, is boosting wider adoption of GLP-1 drugs
Even though this correlation has been verified, its specific mechanisms are not fully understood
Others may experience side effects that necessitate discontinuation
